Multiple metalloproteinases hydrolyze MICA and MICB and convert them into soluble ligand molecules that inhibit NKG2D signal activation and impede the killing of tumor cells by NK cells and CD8+ T cells. The gene discussed is MICB; the disease is neoplasm.